ITCMDBv1
Clinical TrialID 523

Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study

NCT00176046

Metastatic Breast Cancer

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
523
Evidence Id
523
Core Evidence Id
523
Source Clinical Trial Id
506
Herb2 Clinical Trial Id
HBCT000506
Nct Id
NCT00176046
Title
Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
Status
Completed
Phase
Phase 4
Study Result
No
Study Condition
Metastatic Breast Cancer
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: viscum album pini|DRUG: viscum album pini
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
Female
Age
Adult, Older_Adult
Enrollment
114
Outcome Measure
blood count, 6-30 months|lymphocytes, 6-30 months|lymphocyte stimulation, 4 months|quality of life, 6-30 months|anxiety and depression, 6-30 months|diurnal profile of cortisol, 6-30 months|expression of zeta-chains on T- and NK-cells, 6-30 months
Sponsor Collaborator
Heidelberg University|Verein für Krebsforschung, Arlesheim, Swizzerland|Weleda AG, D-73525 Schwäbisch Gmünd
Funded By
OTHER
Location
Department of Complementary and Integrative Medicine, Heidelberg, Baden-Württemberg, D-69120, Germany
Other Id
WD 40
Start Date
1999-05
Primary Completion Date
2009-06
Completion Date
2009-07
First Posted
2005-09-15
Results First Posted
Last Update Posted
2017-05-08
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00176046
Title Cn
Title En
Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
Bilingual Status
semi_complete